Sei Investments Co. decreased its stake in shares of Intuitive Surgical Inc. (NASDAQ:ISRG) by 0.7% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 27,295 shares of the company’s stock after selling 180 shares during the period. Sei Investments Co. owned approximately 0.07% of Intuitive Surgical worth $19,784,000 at the end of the most recent reporting period.

Several other institutional investors have also recently modified their holdings of ISRG. Acropolis Investment Management LLC purchased a new position in shares of Intuitive Surgical during the third quarter valued at about $109,000. Global X Management Co. LLC purchased a new position in shares of Intuitive Surgical during the second quarter valued at about $118,000. Bartlett & Co. LLC raised its position in shares of Intuitive Surgical by 7.3% in the second quarter. Bartlett & Co. LLC now owns 220 shares of the company’s stock valued at $146,000 after buying an additional 15 shares during the period. Glenmede Trust Co. NA raised its position in shares of Intuitive Surgical by 3.0% in the second quarter. Glenmede Trust Co. NA now owns 275 shares of the company’s stock valued at $181,000 after buying an additional 8 shares during the period. Finally, Stonebridge Capital Management Inc. purchased a new position in shares of Intuitive Surgical during the third quarter valued at about $209,000. 90.64% of the stock is currently owned by institutional investors and hedge funds.

Institutional Ownership by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Intuitive Surgical Inc. (NASDAQ:ISRG) traded up 0.8968% on Tuesday, reaching $653.4986. The company’s stock had a trading volume of 59,971 shares. The company has a market cap of $25.32 billion, a P/E ratio of 35.2480 and a beta of 0.55. The firm’s 50-day moving average price is $671.47 and its 200 day moving average price is $673.58. Intuitive Surgical Inc. has a 52-week low of $502.01 and a 52-week high of $727.25.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Tuesday, October 18th. The company reported $6.19 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $5.13 by $1.06. The company had revenue of $682.90 million for the quarter, compared to the consensus estimate of $650.49 million. Intuitive Surgical had a return on equity of 15.02% and a net margin of 27.51%. The firm’s revenue was up 15.8% compared to the same quarter last year. During the same period in the previous year, the business earned $5.24 EPS. Equities analysts anticipate that Intuitive Surgical Inc. will post $22.19 EPS for the current fiscal year.

TRADEMARK VIOLATION WARNING: This piece was first published by The Cerbat Gem and is the propert of of The Cerbat Gem. If you are accessing this piece on another domain, it was illegally stolen and reposted in violation of U.S. and international copyright law. The original version of this piece can be read at https://www.thecerbatgem.com/2016/11/29/sei-investments-co-decreases-position-in-intuitive-surgical-inc-isrg.html.

Several brokerages have recently issued reports on ISRG. Barclays PLC reaffirmed an “overweight” rating and set a $760.00 price target (up previously from $750.00) on shares of Intuitive Surgical in a research note on Friday, October 21st. Canaccord Genuity upped their price target on Intuitive Surgical from $750.00 to $800.00 and gave the company a “buy” rating in a research note on Wednesday, October 19th. Zacks Investment Research raised Intuitive Surgical from a “hold” rating to a “buy” rating and set a $753.00 target price on the stock in a research note on Wednesday, September 14th. Wedbush reissued an “outperform” rating and issued a $755.00 target price (down previously from $785.00) on shares of Intuitive Surgical in a research note on Wednesday, October 19th. Finally, BTIG Research reissued a “hold” rating on shares of Intuitive Surgical in a research note on Tuesday, September 20th. One investment analyst has rated the stock with a sell rating, six have given a hold rating, fourteen have assigned a buy rating and one has issued a strong buy rating to the stock. Intuitive Surgical currently has an average rating of “Buy” and a consensus target price of $729.50.

In other news, CEO Gary S. Guthart sold 13,515 shares of the business’s stock in a transaction dated Monday, November 7th. The stock was sold at an average price of $680.68, for a total value of $9,199,390.20. Following the transaction, the chief executive officer now directly owns 82,880 shares of the company’s stock, valued at approximately $56,414,758.40. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Lonnie M. Smith sold 275 shares of the company’s stock in a transaction that occurred on Thursday, November 17th. The stock was sold at an average price of $646.50, for a total value of $177,787.50. Following the transaction, the director now directly owns 235,890 shares in the company, valued at $152,502,885. The disclosure for this sale can be found here. 3.10% of the stock is owned by insiders.

About Intuitive Surgical

Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.

5 Day Chart for NASDAQ:ISRG

Receive News & Stock Ratings for Intuitive Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical Inc. and related stocks with our FREE daily email newsletter.